Technology News

Technology stock news including AI, semiconductors, cloud computing, and software. Coverage of Big Tech earnings, product launches, and sector trends.

Microsoft Stock Dips on Rate Fears Despite Strong Cloud Demand
Technology Sarah Chen

Microsoft Stock Dips on Rate Fears Despite Strong Cloud Demand

Microsoft shares slipped 1.4% to $417.42 on Tuesday as higher Treasury yields weighed on big tech, even as the company announced its largest India data center will open by mid-2026.

MSFT GOOGL AMZN NVDA
Super Micro Stock Dips as Sales Leadership Change Adds to Investor Caution
Technology Sarah Chen

Super Micro Stock Dips as Sales Leadership Change Adds to Investor Caution

Super Micro Computer shares slipped 0.9% Tuesday after a filing disclosed the retirement of longtime sales chief Don Clegg, adding to investor concerns about governance and competition.

SMCI NVDA AMD INTC HPE DELL
Google's $5B AI Cloud Deal with Blackstone Fails to Impress Wall Street
Technology Sarah Chen

Google's $5B AI Cloud Deal with Blackstone Fails to Impress Wall Street

Alphabet shares dropped 2.3% as Google's $5B AI cloud venture with Blackstone and new Gemini models failed to meet Wall Street's high expectations.

GOOGL GOOG BLK NVDA
AST SpaceMobile Stock Rebounds Amid Satellite Launch Optimism
Technology Sarah Chen

AST SpaceMobile Stock Rebounds Amid Satellite Launch Optimism

AST SpaceMobile shares recovered from early losses to close 2.2% higher at $88.75, as market focus shifted to the company's ambitious plan to launch 45 BlueBird satellites this year.

ASTS T VZ TMUS S AMZN RKLB QQQ SPY
Warby Parker Stock Dips After AI Glasses Reveal Leaves Key Details Unclear
Technology Sarah Chen

Warby Parker Stock Dips After AI Glasses Reveal Leaves Key Details Unclear

Warby Parker shares slipped after revealing AI glasses with Google and Samsung, but missing pricing and launch date. Q1 revenue rose 8.3% to $242.4M, while gross margin fell to 54%.

WRBY GOOGL SSNLF META
Intel Rebounds on CPU Demand Hopes Ahead of Nvidia's Earnings
Technology Sarah Chen

Intel Rebounds on CPU Demand Hopes Ahead of Nvidia's Earnings

Intel shares climbed 3.3% to $111.69, breaking a five-session losing streak, after analysts raised price targets on stronger CPU demand. The move precedes Nvidia's earnings.

INTC NVDA AMD
Autonomous Trucking Sector Shifts to Paid Operations, Investors Eye Scalability
Technology Sarah Chen

Autonomous Trucking Sector Shifts to Paid Operations, Investors Eye Scalability

Aurora Innovation and Kodiak report paid driverless freight runs in Texas, while Waabi raises $750M. Investors focus on scalability and cost per mile.

AUR
Astera Labs Soars on AI Demand, Wall Street Bullish on Connectivity
Technology Sarah Chen

Astera Labs Soars on AI Demand, Wall Street Bullish on Connectivity

Astera Labs shares jumped 15.2% to $248.36 after Evercore ISI boosted its price target and management cited rising AI data-center demand. Revenue surged to $308 million last quarter.

ALAB NVDA MRVL AVGO
Celestica Shares Slip as AI Hardware Rally Falters
Technology Sarah Chen

Celestica Shares Slip as AI Hardware Rally Falters

Celestica shares dropped 5% in Toronto as the TSX reopened, mirroring declines in New York, as AI hardware stocks faced a sell-off.

CLS JBL FLEX SANM
Anthropic Bolsters AI Research with Key Hires Including OpenAI Co-Founder
Technology Sarah Chen

Anthropic Bolsters AI Research with Key Hires Including OpenAI Co-Founder

Anthropic hires OpenAI co-founder Andrej Karpathy to its pre-training team, aiming to accelerate Claude model development with AI-driven research.

MSFT GOOGL XLK
Technology Sarah Chen

Seagate Stock Slips on Supply Constraints Amid AI Storage Surge

Seagate shares dropped again Tuesday after CEO Dave Mosley said new factories take too long to meet AI demand, focusing on tech upgrades instead.

STX WDC SNDK MU
Technology Sarah Chen

Relay Therapeutics Surges on Promising Vascular Anomaly Data

Relay Therapeutics shares surged 11.3% premarket after reporting a 60% volumetric response rate from its Phase 2 trial of zovegalisib for vascular anomalies, with no patient discontinuations due to adverse events.

RLAY